ANDE vs IPAR
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Andersons, Inc. (ANDE) exhibits mixed signals across the Advanced Deterministic Scorecard: a Piotroski F-Score of 4/9 indicates weak financial health, while the absence of an Altman Z-Score raises concern about default risk. The stock trades near its intrinsic value of $82.31 but at a premium to the Graham Number of $48.28, suggesting high growth expectations are priced in. Despite strong earnings growth (51.4% YoY) and a recent surge in EPS (142.9% Q/Q), revenue has declined sharply (-18.8% YoY), signaling underlying business headwinds. Insider selling activity and a bearish technical trend further temper optimism.
IPAR exhibits exceptional financial health, highlighted by a perfect Piotroski F-Score of 9/9 and a very low Debt/Equity ratio of 0.19. While the current price of $93.00 sits above the conservative Graham Number ($56.90), it remains significantly discounted relative to its growth-based intrinsic value of $154.58 and the sector average P/E of 31.82. Despite bearish short-term technicals and recent insider selling, the company's strong ROE (20.34%) and consistent earnings beat track record suggest a high-quality compounder. The valuation gap between the current price and the analyst target of $111.20 provides a compelling margin of safety.
Compare Another Pair
Related Comparisons
ANDE vs IPAR: Head-to-Head Comparison
This page compares The Andersons, Inc. (ANDE) and Interparfums, Inc. (IPAR) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.